title: Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities.
authors.forename: Maria Rita
authors.initials: MR
authors.lastname: Taliani
authors.forename: Cecilia
authors.initials: C
authors.lastname: Becattini
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Agnelli
authors.forename: Paolo
authors.initials: P
authors.lastname: Prandoni
authors.forename: Marco
authors.initials: M
authors.lastname: Moia
authors.forename: Mario
authors.initials: M
authors.lastname: Bazzan
authors.forename: Rosamaria
authors.initials: R
authors.lastname: Salvi
authors.forename: Walter
authors.initials: W
authors.lastname: Ageno
authors.forename: Giuliana
authors.initials: G
authors.lastname: Guazzaloca
authors.forename: Davide
authors.initials: D
authors.lastname: Imberti
authors.forename: Mauro
authors.initials: M
authors.lastname: Silingardi
authors.forename: Renzo
authors.initials: R
authors.lastname: Poggio
mesh_terms: D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012307:Risk Factors; D019851:Thrombophilia / Q000150:complications*; D013997:Time Factors; D054556:Venous Thromboembolism / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants